VBI Vaccines
VBIV
#10529
Rank
$1.87 M
Marketcap
$0.06530
Share price
0.00%
Change (1 day)
-89.30%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): -$10.14

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is -$10.14. In 2022 the company made an earnings per share (EPS) of -$13.20 a decrease over its 2021 EPS that were of -$8.10.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$10.14
2022-$13.2062.96%
2021-$8.1028.57%
2020-$6.30-54.35%
2019-$13.80-52.58%
2018-$29.1010.23%
2017-$26.4014.29%
2016-$23.10-62.8%
2015-$62.1090.68%
2014-$32.57-7.95%
2013-$35.38-57.97%
2012-$84.19-78%
2011-$382.753151.47%
2010-$11.7723.87%
2009-$9.50-18.48%
2008-$11.6612.08%
2007-$10.40-49.47%
2006-$20.59
2005N/A-100%
2004-$9.1511.94%
2003-$8.18-81.89%
2002-$45.14196.44%
2001-$15.2384.33%
2000-$8.26-65.37%
1999-$23.86-29.45%
1998-$33.8129.61%
1997-$26.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-$0.95-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-$4.33-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-$3.67-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA